Healthy Upside Potential: Accelerate Diagnostics Inc. (AXDX)

Accelerate Diagnostics Inc. (NASDAQ: AXDX) stock jumped 0.03% on Wednesday to $0.95 against a previous-day closing price of $0.95. With 0.42 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.52 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $0.9891 whereas the lowest price it dropped to was $0.8507. The 52-week range on AXDX shows that it touched its highest point at $5.65 and its lowest point at $0.50 during that stretch. It currently has a 1-year price target of $2.00. Beta for the stock currently stands at 1.17.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.

Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AXDX was down-trending over the past week, with a drop of -15.50%, but this was down by -16.98% over a month. Three-month performance dropped to -44.33% while six-month performance rose 72.51%. The stock lost -81.76% in the past year, while it has lost -81.87% so far this year. A look at the trailing 12-month EPS for AXDX yields -0.97 with Next year EPS estimates of -0.54. For the next quarter, that number is -0.15. This implies an EPS growth rate of 9.80% for this year and 30.30% for next year. EPS is expected to grow by 30.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 0.60%.

Float and Shares Shorts:

At present, 87.01 million AXDX shares are outstanding with a float of 73.31 million shares on hand for trading. On Oct 13, 2022, short shares totaled 4.82 million, which was 4.86% higher than short shares on Sep 14, 2022. In addition to Mr. Jack Phillips as the firm’s CEO, Pres & Director, Mr. Steve Reichling serves as its Chief Financial Officer.


Institutional Ownership:

Through their ownership of 22.47% of AXDX’s outstanding shares, institutional investors have minority control over the company. Other institutions hold — of AXDX, in contrast to — held by mutual funds. Shares owned by individuals account for –. With a 2.26% stake in AXDX, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 2,234,561 shares are owned by the mutual fund manager. The AXA IM AXA IM Global Robot Relate, which owns about 0.68% of AXDX stock, is the second-largest Mutual Fund holder. It holds 676,167 shares valued at 0.86 million. Vanguard Extended Market Index Fu holds 0.54% of the stake in AXDX, owning 531,960 shares worth 0.68 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AXDX since 2 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With AXDX analysts setting a high price target of $2.00 and a low target of $2.00, the average target price over the next 12 months is $2.00. Based on these targets, AXDX could surge 110.53% to reach the target high and rise by 110.53% to reach the target low. Reaching the average price target will result in a growth of 110.53% from current levels.


EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. AXDX will report FY 2022 earnings on 03/01/2023. Analysts have provided yearly estimates in a range of -$0.77 being high and -$0.79 being low. For AXDX, this leads to a yearly average estimate of -$0.78. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Accelerate Diagnostics Inc. surprised analysts by $0.03 when it reported -$0.17 EPS against a consensus estimate of -$0.20. The surprise factor in the prior quarter was $0.10. Based on analyst estimates, the high estimate for the next quarter is -$0.13 and the low estimate is -$0.16. The average estimate for the next quarter is thus -$0.14.

Summary of Insider Activity:

Insiders traded AXDX stock several times over the past three months with 1 Buys and 0 Sells. In these transactions, 50,000 shares were bought while 0 shares were sold. The number of buy transactions has increased to 22 while that of sell transactions has risen to 5 over the past year. The total number of shares bought during that period was 1,917,930 while 160,546 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *

1406

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.

Receive Best Stock To Trade Before The Opening Bell

 

 

100% Free. Stop Anytime. No Spam